Progressive Corporation (PGR)

Cash & Short-Term Investments

$2.13B

Quarterly · Period ending: · USD

PGR logo

PGR Cash & Short-Term Investments

Latest reported$2.13B
PGR Quarterly Cash & Short-Term Investments ($0.00 → $2.13B)
High-resolution chart · PNG

PGR cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Progressive Corporation Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
2,125,000,000
2,156,000,000
2,288,000,000
19,836,000,000
10,356,000,000
10,775,000,000
11,276,000,000
76,090,000,000
8,745,400,000
72,445,700,000
69,192,500,000
62,253,000,000
61,994,000,000
59,429,500,000
53,087,000,000
49,717,100,000
48,761,600,000
48,010,400,000
47,119,000,000
45,002,800,000
46,405,000,000
44,841,100,000
41,457,800,000
42,105,900,000
41,071,400,000
39,534,900,000
37,170,300,000
35,135,300,000
34,326,000,000
32,641,000,000
30,564,600,000
29,976,900,000
28,574,300,000
27,175,200,000
25,662,600,000
23,336,100,000
23,196,400,000
22,278,800,000
20,729,600,000
20,028,200,000
19,936,500,000
18,890,600,000
18,003,200,000
17,728,300,000
17,948,600,000
17,522,100,000
16,588,300,000
15,806,600,000
16,031,100,000
15,743,400,000
14,475,800,000
14,888,100,000
15,044,700,000
14,604,400,000
14,478,200,000
13,943,200,000
2,586,300,000
1,844,700,000
1,676,100,000
13,466,800,000
1,870,000,000
1,493,200,000
1,283,900,000
1,249,700,000
14,056,300,000
1,802,700,000
1,544,300,000
1,238,700,000
1,400,400,000
1,297,900,000
1,428,300,000
1,156,500,000
740,400,000
523,100,000
1,541,800,000
388,200,000
381,800,000
292,000,000
604,200,000
586,800,000
1,072,400,000
737,900,000
719,100,000
779,200,000
926,100,000
2,286,500,000
1,059,600,000
1,396,900,000
2,238,700,000
1,136,800,000
1,136,700,000
660,100,000
655,400,000
1,141,500,000
851,600,000
584,700,000
582,700,000
464,200,000
444,800,000
238,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.